Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial-Reference-Cited by-同舟云学术

Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial

Published:2023-04 Issue: Volume:181 Page:109505
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Cui Tianxiang,Zhang Anmei,Cui Jianxiong,Chen Lu,Chen Guangpeng,Dai Hongya,Qin Xianli,Li Guanghui,Sun Jianguo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference38 articles.

1. Precision medicine in non-small cell lung cancer: current standards in pathology and biomarker interpretation;Brown;Am Soc Clin Oncol Educ Book,2018

2. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: report of Radiation Therapy Oncology Group (RTOG) protocol 97–12;Komaki;Int J Radiat Oncol Biol Phys,2005

3. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study

4. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer;Nestle;Radiother Oncol,2018

5. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study;De Ruysscher;Int J Radiat Oncol Biol Phys,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric comparison of nodal clinical target volume for locally advanced non‑small cell lung cancer: Options for geometric expansion vs. lymph node stations;Molecular and Clinical Oncology;2024-06-26

2. Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?;Cancer Biology & Medicine;2024-02-05

3. Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis;Radiotherapy and Oncology;2024-01

4. Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation;International Journal of Radiation Oncology*Biology*Physics;2023-08